nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A5—Dactinomycin—kidney cancer	0.161	0.254	CbGbCtD
Ipratropium bromide—CYP2D6—Temsirolimus—kidney cancer	0.0803	0.126	CbGbCtD
Ipratropium bromide—CYP3A4—Everolimus—kidney cancer	0.0756	0.119	CbGbCtD
Ipratropium bromide—CYP3A4—Temsirolimus—kidney cancer	0.0511	0.0803	CbGbCtD
Ipratropium bromide—CYP2D6—Pazopanib—kidney cancer	0.0422	0.0664	CbGbCtD
Ipratropium bromide—CYP2D6—Erlotinib—kidney cancer	0.0301	0.0474	CbGbCtD
Ipratropium bromide—CYP3A4—Pazopanib—kidney cancer	0.0268	0.0422	CbGbCtD
Ipratropium bromide—CYP2D6—Sorafenib—kidney cancer	0.0245	0.0385	CbGbCtD
Ipratropium bromide—CYP2D6—Vinblastine—kidney cancer	0.0242	0.038	CbGbCtD
Ipratropium bromide—CHRM3—ureter—kidney cancer	0.0199	0.415	CbGeAlD
Ipratropium bromide—CYP3A4—Erlotinib—kidney cancer	0.0191	0.0301	CbGbCtD
Ipratropium bromide—CYP3A4—Paclitaxel—kidney cancer	0.0175	0.0276	CbGbCtD
Ipratropium bromide—CYP3A4—Sorafenib—kidney cancer	0.0156	0.0245	CbGbCtD
Ipratropium bromide—CYP3A4—Vinblastine—kidney cancer	0.0154	0.0242	CbGbCtD
Ipratropium bromide—CYP3A4—Vincristine—kidney cancer	0.0151	0.0238	CbGbCtD
Ipratropium bromide—CYP2D6—Doxorubicin—kidney cancer	0.0149	0.0234	CbGbCtD
Ipratropium bromide—CYP3A4—Sunitinib—kidney cancer	0.0126	0.0198	CbGbCtD
Ipratropium bromide—CYP3A4—Doxorubicin—kidney cancer	0.00944	0.0149	CbGbCtD
Ipratropium bromide—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00604	1	CbGdCrCtD
Ipratropium bromide—CYP3A4—urine—kidney cancer	0.00356	0.0741	CbGeAlD
Ipratropium bromide—CYP2D6—urine—kidney cancer	0.0035	0.0729	CbGeAlD
Ipratropium bromide—SLC22A4—nephron tubule—kidney cancer	0.00221	0.0459	CbGeAlD
Ipratropium bromide—SLC22A4—renal system—kidney cancer	0.00201	0.0418	CbGeAlD
Ipratropium bromide—SLC22A4—kidney—kidney cancer	0.00194	0.0404	CbGeAlD
Ipratropium bromide—SLC22A4—cortex of kidney—kidney cancer	0.00189	0.0393	CbGeAlD
Ipratropium bromide—CHRM3—renal system—kidney cancer	0.00159	0.033	CbGeAlD
Ipratropium bromide—CHRM3—kidney—kidney cancer	0.00153	0.0319	CbGeAlD
Ipratropium bromide—SLC22A5—nephron tubule—kidney cancer	0.00146	0.0304	CbGeAlD
Ipratropium bromide—SLC22A5—renal system—kidney cancer	0.00133	0.0276	CbGeAlD
Ipratropium bromide—SLC22A5—kidney—kidney cancer	0.00128	0.0267	CbGeAlD
Ipratropium bromide—SLC22A5—cortex of kidney—kidney cancer	0.00125	0.026	CbGeAlD
Ipratropium bromide—SLC22A5—cardiac atrium—kidney cancer	0.00119	0.0247	CbGeAlD
Ipratropium bromide—CYP3A4—renal system—kidney cancer	0.000871	0.0181	CbGeAlD
Ipratropium bromide—CYP2D6—renal system—kidney cancer	0.000857	0.0178	CbGeAlD
Ipratropium bromide—CYP3A4—kidney—kidney cancer	0.000842	0.0175	CbGeAlD
Ipratropium bromide—CYP2D6—kidney—kidney cancer	0.000829	0.0172	CbGeAlD
Ipratropium bromide—Hypotension—Vincristine—kidney cancer	0.00028	0.000914	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Gemcitabine—kidney cancer	0.000279	0.00091	CcSEcCtD
Ipratropium bromide—Haemoglobin—Capecitabine—kidney cancer	0.000276	0.000902	CcSEcCtD
Ipratropium bromide—Skin disorder—Gemcitabine—kidney cancer	0.000276	0.000901	CcSEcCtD
Ipratropium bromide—Rhinitis—Capecitabine—kidney cancer	0.000275	0.000899	CcSEcCtD
Ipratropium bromide—Haemorrhage—Capecitabine—kidney cancer	0.000275	0.000897	CcSEcCtD
Ipratropium bromide—Vision blurred—Paclitaxel—kidney cancer	0.000275	0.000897	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Gemcitabine—kidney cancer	0.000275	0.000897	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000274	0.000895	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Capecitabine—kidney cancer	0.000273	0.000893	CcSEcCtD
Ipratropium bromide—Tremor—Paclitaxel—kidney cancer	0.000273	0.000892	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000273	0.000891	CcSEcCtD
Ipratropium bromide—Pharyngitis—Capecitabine—kidney cancer	0.000273	0.00089	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Capecitabine—kidney cancer	0.000271	0.000886	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Sorafenib—kidney cancer	0.000271	0.000885	CcSEcCtD
Ipratropium bromide—Insomnia—Vincristine—kidney cancer	0.000271	0.000884	CcSEcCtD
Ipratropium bromide—Vomiting—Vinblastine—kidney cancer	0.000271	0.000883	CcSEcCtD
Ipratropium bromide—Dizziness—Erlotinib—kidney cancer	0.00027	0.000883	CcSEcCtD
Ipratropium bromide—Vomiting—Everolimus—kidney cancer	0.00027	0.00088	CcSEcCtD
Ipratropium bromide—Urethral disorder—Capecitabine—kidney cancer	0.000269	0.000879	CcSEcCtD
Ipratropium bromide—Paraesthesia—Vincristine—kidney cancer	0.000269	0.000878	CcSEcCtD
Ipratropium bromide—Rash—Everolimus—kidney cancer	0.000267	0.000873	CcSEcCtD
Ipratropium bromide—Dermatitis—Everolimus—kidney cancer	0.000267	0.000872	CcSEcCtD
Ipratropium bromide—Headache—Vinblastine—kidney cancer	0.000267	0.00087	CcSEcCtD
Ipratropium bromide—Angioedema—Paclitaxel—kidney cancer	0.000266	0.00087	CcSEcCtD
Ipratropium bromide—Headache—Everolimus—kidney cancer	0.000266	0.000867	CcSEcCtD
Ipratropium bromide—Hypotension—Gemcitabine—kidney cancer	0.000265	0.000867	CcSEcCtD
Ipratropium bromide—Abdominal pain—Dactinomycin—kidney cancer	0.000265	0.000865	CcSEcCtD
Ipratropium bromide—Visual impairment—Capecitabine—kidney cancer	0.000265	0.000865	CcSEcCtD
Ipratropium bromide—Asthenia—Sorafenib—kidney cancer	0.000264	0.000862	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Sunitinib—kidney cancer	0.000261	0.000852	CcSEcCtD
Ipratropium bromide—Pruritus—Sorafenib—kidney cancer	0.00026	0.00085	CcSEcCtD
Ipratropium bromide—Vomiting—Erlotinib—kidney cancer	0.00026	0.000849	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000259	0.000845	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000259	0.000844	CcSEcCtD
Ipratropium bromide—Fatigue—Vincristine—kidney cancer	0.000258	0.000843	CcSEcCtD
Ipratropium bromide—Rash—Erlotinib—kidney cancer	0.000258	0.000842	CcSEcCtD
Ipratropium bromide—Dermatitis—Erlotinib—kidney cancer	0.000258	0.000841	CcSEcCtD
Ipratropium bromide—Palpitations—Paclitaxel—kidney cancer	0.000258	0.000841	CcSEcCtD
Ipratropium bromide—Insomnia—Gemcitabine—kidney cancer	0.000257	0.000839	CcSEcCtD
Ipratropium bromide—Eye disorder—Capecitabine—kidney cancer	0.000257	0.000838	CcSEcCtD
Ipratropium bromide—Headache—Erlotinib—kidney cancer	0.000256	0.000837	CcSEcCtD
Ipratropium bromide—Tinnitus—Capecitabine—kidney cancer	0.000256	0.000836	CcSEcCtD
Ipratropium bromide—Pain—Vincristine—kidney cancer	0.000256	0.000836	CcSEcCtD
Ipratropium bromide—Constipation—Vincristine—kidney cancer	0.000256	0.000836	CcSEcCtD
Ipratropium bromide—Paraesthesia—Gemcitabine—kidney cancer	0.000255	0.000833	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Capecitabine—kidney cancer	0.000255	0.000833	CcSEcCtD
Ipratropium bromide—Flushing—Capecitabine—kidney cancer	0.000255	0.000833	CcSEcCtD
Ipratropium bromide—Cough—Paclitaxel—kidney cancer	0.000254	0.00083	CcSEcCtD
Ipratropium bromide—Asthenia—Sunitinib—kidney cancer	0.000254	0.000829	CcSEcCtD
Ipratropium bromide—Dyspnoea—Gemcitabine—kidney cancer	0.000253	0.000827	CcSEcCtD
Ipratropium bromide—Nausea—Vinblastine—kidney cancer	0.000253	0.000825	CcSEcCtD
Ipratropium bromide—Somnolence—Gemcitabine—kidney cancer	0.000253	0.000825	CcSEcCtD
Ipratropium bromide—Nausea—Everolimus—kidney cancer	0.000252	0.000822	CcSEcCtD
Ipratropium bromide—Diarrhoea—Sorafenib—kidney cancer	0.000252	0.000822	CcSEcCtD
Ipratropium bromide—Hypertension—Paclitaxel—kidney cancer	0.000252	0.000822	CcSEcCtD
Ipratropium bromide—Pruritus—Sunitinib—kidney cancer	0.000251	0.000818	CcSEcCtD
Ipratropium bromide—Immune system disorder—Capecitabine—kidney cancer	0.000248	0.00081	CcSEcCtD
Ipratropium bromide—Myalgia—Paclitaxel—kidney cancer	0.000248	0.00081	CcSEcCtD
Ipratropium bromide—Chest pain—Paclitaxel—kidney cancer	0.000248	0.00081	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Capecitabine—kidney cancer	0.000248	0.000808	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Dactinomycin—kidney cancer	0.000247	0.000806	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000246	0.000805	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000245	0.000801	CcSEcCtD
Ipratropium bromide—Fatigue—Gemcitabine—kidney cancer	0.000245	0.0008	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Vincristine—kidney cancer	0.000245	0.0008	CcSEcCtD
Ipratropium bromide—Dizziness—Sorafenib—kidney cancer	0.000243	0.000794	CcSEcCtD
Ipratropium bromide—Constipation—Gemcitabine—kidney cancer	0.000243	0.000793	CcSEcCtD
Ipratropium bromide—Pain—Gemcitabine—kidney cancer	0.000243	0.000793	CcSEcCtD
Ipratropium bromide—Nausea—Erlotinib—kidney cancer	0.000243	0.000793	CcSEcCtD
Ipratropium bromide—Dry mouth—Paclitaxel—kidney cancer	0.000243	0.000792	CcSEcCtD
Ipratropium bromide—Diarrhoea—Sunitinib—kidney cancer	0.000242	0.000791	CcSEcCtD
Ipratropium bromide—Asthenia—Dactinomycin—kidney cancer	0.000241	0.000785	CcSEcCtD
Ipratropium bromide—Oedema—Paclitaxel—kidney cancer	0.000238	0.000777	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Paclitaxel—kidney cancer	0.000238	0.000777	CcSEcCtD
Ipratropium bromide—Abdominal pain—Vincristine—kidney cancer	0.000237	0.000773	CcSEcCtD
Ipratropium bromide—Infection—Paclitaxel—kidney cancer	0.000236	0.000772	CcSEcCtD
Ipratropium bromide—Flatulence—Capecitabine—kidney cancer	0.000236	0.00077	CcSEcCtD
Ipratropium bromide—Dysgeusia—Capecitabine—kidney cancer	0.000234	0.000765	CcSEcCtD
Ipratropium bromide—Dizziness—Sunitinib—kidney cancer	0.000234	0.000764	CcSEcCtD
Ipratropium bromide—Vomiting—Sorafenib—kidney cancer	0.000234	0.000764	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Paclitaxel—kidney cancer	0.000233	0.000762	CcSEcCtD
Ipratropium bromide—Tachycardia—Paclitaxel—kidney cancer	0.000232	0.000758	CcSEcCtD
Ipratropium bromide—Rash—Sorafenib—kidney cancer	0.000232	0.000758	CcSEcCtD
Ipratropium bromide—Dermatitis—Sorafenib—kidney cancer	0.000232	0.000757	CcSEcCtD
Ipratropium bromide—Back pain—Capecitabine—kidney cancer	0.000231	0.000755	CcSEcCtD
Ipratropium bromide—Skin disorder—Paclitaxel—kidney cancer	0.000231	0.000754	CcSEcCtD
Ipratropium bromide—Headache—Sorafenib—kidney cancer	0.000231	0.000753	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Paclitaxel—kidney cancer	0.00023	0.000751	CcSEcCtD
Ipratropium bromide—Diarrhoea—Dactinomycin—kidney cancer	0.000229	0.000749	CcSEcCtD
Ipratropium bromide—Vision blurred—Capecitabine—kidney cancer	0.000225	0.000736	CcSEcCtD
Ipratropium bromide—Vomiting—Sunitinib—kidney cancer	0.000225	0.000735	CcSEcCtD
Ipratropium bromide—Tremor—Capecitabine—kidney cancer	0.000224	0.000732	CcSEcCtD
Ipratropium bromide—Rash—Sunitinib—kidney cancer	0.000223	0.000729	CcSEcCtD
Ipratropium bromide—Dermatitis—Sunitinib—kidney cancer	0.000223	0.000728	CcSEcCtD
Ipratropium bromide—Hypotension—Paclitaxel—kidney cancer	0.000222	0.000726	CcSEcCtD
Ipratropium bromide—Headache—Sunitinib—kidney cancer	0.000222	0.000724	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—kidney cancer	0.000221	0.000722	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—kidney cancer	0.000221	0.000722	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—kidney cancer	0.000221	0.000722	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Vincristine—kidney cancer	0.000221	0.00072	CcSEcCtD
Ipratropium bromide—Nausea—Sorafenib—kidney cancer	0.000219	0.000714	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000217	0.000708	CcSEcCtD
Ipratropium bromide—Insomnia—Paclitaxel—kidney cancer	0.000215	0.000702	CcSEcCtD
Ipratropium bromide—Asthenia—Vincristine—kidney cancer	0.000215	0.000702	CcSEcCtD
Ipratropium bromide—Paraesthesia—Paclitaxel—kidney cancer	0.000214	0.000697	CcSEcCtD
Ipratropium bromide—Vomiting—Dactinomycin—kidney cancer	0.000213	0.000696	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—kidney cancer	0.000213	0.000695	CcSEcCtD
Ipratropium bromide—Dyspnoea—Paclitaxel—kidney cancer	0.000212	0.000692	CcSEcCtD
Ipratropium bromide—Somnolence—Paclitaxel—kidney cancer	0.000211	0.00069	CcSEcCtD
Ipratropium bromide—Palpitations—Capecitabine—kidney cancer	0.000211	0.00069	CcSEcCtD
Ipratropium bromide—Rash—Dactinomycin—kidney cancer	0.000211	0.00069	CcSEcCtD
Ipratropium bromide—Nausea—Sunitinib—kidney cancer	0.00021	0.000687	CcSEcCtD
Ipratropium bromide—Dyspepsia—Paclitaxel—kidney cancer	0.000209	0.000684	CcSEcCtD
Ipratropium bromide—Cough—Capecitabine—kidney cancer	0.000209	0.000681	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—kidney cancer	0.000207	0.000676	CcSEcCtD
Ipratropium bromide—Hypertension—Capecitabine—kidney cancer	0.000207	0.000674	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000206	0.000671	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000205	0.00067	CcSEcCtD
Ipratropium bromide—Fatigue—Paclitaxel—kidney cancer	0.000205	0.00067	CcSEcCtD
Ipratropium bromide—Diarrhoea—Vincristine—kidney cancer	0.000205	0.000669	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—kidney cancer	0.000204	0.000667	CcSEcCtD
Ipratropium bromide—Asthenia—Gemcitabine—kidney cancer	0.000204	0.000666	CcSEcCtD
Ipratropium bromide—Chest pain—Capecitabine—kidney cancer	0.000204	0.000665	CcSEcCtD
Ipratropium bromide—Myalgia—Capecitabine—kidney cancer	0.000204	0.000665	CcSEcCtD
Ipratropium bromide—Pain—Paclitaxel—kidney cancer	0.000203	0.000664	CcSEcCtD
Ipratropium bromide—Constipation—Paclitaxel—kidney cancer	0.000203	0.000664	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000202	0.00066	CcSEcCtD
Ipratropium bromide—Pruritus—Gemcitabine—kidney cancer	0.000201	0.000656	CcSEcCtD
Ipratropium bromide—Dry mouth—Capecitabine—kidney cancer	0.000199	0.00065	CcSEcCtD
Ipratropium bromide—Nausea—Dactinomycin—kidney cancer	0.000199	0.00065	CcSEcCtD
Ipratropium bromide—Dizziness—Vincristine—kidney cancer	0.000198	0.000647	CcSEcCtD
Ipratropium bromide—Oedema—Capecitabine—kidney cancer	0.000195	0.000637	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000195	0.000635	CcSEcCtD
Ipratropium bromide—Diarrhoea—Gemcitabine—kidney cancer	0.000194	0.000635	CcSEcCtD
Ipratropium bromide—Infection—Capecitabine—kidney cancer	0.000194	0.000633	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000193	0.000631	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—kidney cancer	0.000192	0.000628	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—kidney cancer	0.000192	0.000626	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—kidney cancer	0.000192	0.000626	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Capecitabine—kidney cancer	0.000191	0.000625	CcSEcCtD
Ipratropium bromide—Tachycardia—Capecitabine—kidney cancer	0.000191	0.000622	CcSEcCtD
Ipratropium bromide—Vomiting—Vincristine—kidney cancer	0.00019	0.000622	CcSEcCtD
Ipratropium bromide—Skin disorder—Capecitabine—kidney cancer	0.00019	0.000619	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—kidney cancer	0.000189	0.000618	CcSEcCtD
Ipratropium bromide—Urticaria—Paclitaxel—kidney cancer	0.000189	0.000617	CcSEcCtD
Ipratropium bromide—Rash—Vincristine—kidney cancer	0.000189	0.000617	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Capecitabine—kidney cancer	0.000189	0.000616	CcSEcCtD
Ipratropium bromide—Dermatitis—Vincristine—kidney cancer	0.000189	0.000616	CcSEcCtD
Ipratropium bromide—Abdominal pain—Paclitaxel—kidney cancer	0.000188	0.000614	CcSEcCtD
Ipratropium bromide—Headache—Vincristine—kidney cancer	0.000188	0.000613	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—kidney cancer	0.000186	0.000608	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—kidney cancer	0.000185	0.000604	CcSEcCtD
Ipratropium bromide—Hypotension—Capecitabine—kidney cancer	0.000182	0.000596	CcSEcCtD
Ipratropium bromide—Vomiting—Gemcitabine—kidney cancer	0.000181	0.00059	CcSEcCtD
Ipratropium bromide—Rash—Gemcitabine—kidney cancer	0.000179	0.000585	CcSEcCtD
Ipratropium bromide—Dermatitis—Gemcitabine—kidney cancer	0.000179	0.000584	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—kidney cancer	0.000178	0.000581	CcSEcCtD
Ipratropium bromide—Headache—Gemcitabine—kidney cancer	0.000178	0.000581	CcSEcCtD
Ipratropium bromide—Nausea—Vincristine—kidney cancer	0.000178	0.000581	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000178	0.000581	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—kidney cancer	0.000178	0.00058	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—kidney cancer	0.000177	0.000578	CcSEcCtD
Ipratropium bromide—Insomnia—Capecitabine—kidney cancer	0.000177	0.000576	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000176	0.000575	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—kidney cancer	0.000176	0.000574	CcSEcCtD
Ipratropium bromide—Paraesthesia—Capecitabine—kidney cancer	0.000175	0.000572	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Paclitaxel—kidney cancer	0.000175	0.000572	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—kidney cancer	0.000175	0.000571	CcSEcCtD
Ipratropium bromide—Dyspnoea—Capecitabine—kidney cancer	0.000174	0.000568	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—kidney cancer	0.000174	0.000567	CcSEcCtD
Ipratropium bromide—Dyspepsia—Capecitabine—kidney cancer	0.000172	0.000561	CcSEcCtD
Ipratropium bromide—Visual impairment—Doxorubicin—kidney cancer	0.000171	0.000557	CcSEcCtD
Ipratropium bromide—Asthenia—Paclitaxel—kidney cancer	0.000171	0.000557	CcSEcCtD
Ipratropium bromide—Nausea—Gemcitabine—kidney cancer	0.000169	0.000551	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000169	0.00055	CcSEcCtD
Ipratropium bromide—Fatigue—Capecitabine—kidney cancer	0.000168	0.000549	CcSEcCtD
Ipratropium bromide—Pruritus—Paclitaxel—kidney cancer	0.000168	0.000549	CcSEcCtD
Ipratropium bromide—Pain—Capecitabine—kidney cancer	0.000167	0.000545	CcSEcCtD
Ipratropium bromide—Constipation—Capecitabine—kidney cancer	0.000167	0.000545	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—kidney cancer	0.000166	0.00054	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—kidney cancer	0.000165	0.000539	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—kidney cancer	0.000164	0.000537	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—kidney cancer	0.000164	0.000537	CcSEcCtD
Ipratropium bromide—Diarrhoea—Paclitaxel—kidney cancer	0.000163	0.000531	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—kidney cancer	0.00016	0.000522	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Capecitabine—kidney cancer	0.00016	0.000521	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—kidney cancer	0.00016	0.000521	CcSEcCtD
Ipratropium bromide—Dizziness—Paclitaxel—kidney cancer	0.000157	0.000514	CcSEcCtD
Ipratropium bromide—Urticaria—Capecitabine—kidney cancer	0.000155	0.000506	CcSEcCtD
Ipratropium bromide—Abdominal pain—Capecitabine—kidney cancer	0.000154	0.000504	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—kidney cancer	0.000152	0.000496	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—kidney cancer	0.000151	0.000494	CcSEcCtD
Ipratropium bromide—Vomiting—Paclitaxel—kidney cancer	0.000151	0.000494	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—kidney cancer	0.000151	0.000493	CcSEcCtD
Ipratropium bromide—Rash—Paclitaxel—kidney cancer	0.00015	0.00049	CcSEcCtD
Ipratropium bromide—Dermatitis—Paclitaxel—kidney cancer	0.00015	0.000489	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—kidney cancer	0.00015	0.000489	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—kidney cancer	0.000149	0.000487	CcSEcCtD
Ipratropium bromide—Headache—Paclitaxel—kidney cancer	0.000149	0.000487	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—kidney cancer	0.000145	0.000474	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Capecitabine—kidney cancer	0.000144	0.00047	CcSEcCtD
Ipratropium bromide—Nausea—Paclitaxel—kidney cancer	0.000141	0.000461	CcSEcCtD
Ipratropium bromide—Asthenia—Capecitabine—kidney cancer	0.00014	0.000457	CcSEcCtD
Ipratropium bromide—Pruritus—Capecitabine—kidney cancer	0.000138	0.000451	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—kidney cancer	0.000136	0.000445	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—kidney cancer	0.000135	0.000439	CcSEcCtD
Ipratropium bromide—Diarrhoea—Capecitabine—kidney cancer	0.000134	0.000436	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—kidney cancer	0.000133	0.000435	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—kidney cancer	0.000131	0.000429	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—kidney cancer	0.000131	0.000429	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.00013	0.000426	CcSEcCtD
Ipratropium bromide—Dizziness—Capecitabine—kidney cancer	0.000129	0.000421	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—kidney cancer	0.000128	0.000419	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—kidney cancer	0.000126	0.000411	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—kidney cancer	0.000126	0.000411	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—kidney cancer	0.000125	0.000408	CcSEcCtD
Ipratropium bromide—Vomiting—Capecitabine—kidney cancer	0.000124	0.000405	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—kidney cancer	0.000123	0.000403	CcSEcCtD
Ipratropium bromide—Rash—Capecitabine—kidney cancer	0.000123	0.000402	CcSEcCtD
Ipratropium bromide—Dermatitis—Capecitabine—kidney cancer	0.000123	0.000401	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—kidney cancer	0.000123	0.000401	CcSEcCtD
Ipratropium bromide—Headache—Capecitabine—kidney cancer	0.000122	0.000399	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—kidney cancer	0.000122	0.000399	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—kidney cancer	0.000122	0.000397	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—kidney cancer	0.000118	0.000384	CcSEcCtD
Ipratropium bromide—Nausea—Capecitabine—kidney cancer	0.000116	0.000379	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000115	0.000374	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—kidney cancer	0.000114	0.000372	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—kidney cancer	0.000113	0.000369	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—kidney cancer	0.000112	0.000366	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—kidney cancer	0.000112	0.000365	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—kidney cancer	0.000111	0.000362	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000109	0.000355	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—kidney cancer	0.000108	0.000354	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—kidney cancer	0.000108	0.000351	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—kidney cancer	0.000108	0.000351	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000103	0.000336	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—kidney cancer	0.0001	0.000326	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—kidney cancer	9.95e-05	0.000325	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Doxorubicin—kidney cancer	9.27e-05	0.000303	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—kidney cancer	9.03e-05	0.000295	CcSEcCtD
Ipratropium bromide—Pruritus—Doxorubicin—kidney cancer	8.9e-05	0.000291	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—kidney cancer	8.61e-05	0.000281	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—kidney cancer	8.32e-05	0.000272	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—kidney cancer	8e-05	0.000261	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—kidney cancer	7.93e-05	0.000259	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—kidney cancer	7.93e-05	0.000259	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—kidney cancer	7.88e-05	0.000257	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—kidney cancer	7.47e-05	0.000244	CcSEcCtD
Ipratropium bromide—CHRM1—Signaling Pathways—GRB7—kidney cancer	2.51e-06	0.000651	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GRB7—kidney cancer	2.5e-06	0.000648	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PAK1—kidney cancer	2.49e-06	0.000646	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—JUNB—kidney cancer	2.49e-06	0.000646	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GRB7—kidney cancer	2.47e-06	0.000642	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PGK1—kidney cancer	2.47e-06	0.000641	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.47e-06	0.000641	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CCBL1—kidney cancer	2.46e-06	0.000638	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—LDHB—kidney cancer	2.42e-06	0.000629	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SCARB1—kidney cancer	2.4e-06	0.000622	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS1—kidney cancer	2.37e-06	0.000616	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ITPR2—kidney cancer	2.33e-06	0.000605	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PSMD7—kidney cancer	2.33e-06	0.000604	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ITPR2—kidney cancer	2.32e-06	0.000603	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ITPR2—kidney cancer	2.3e-06	0.000597	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—POMC—kidney cancer	2.3e-06	0.000597	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—BCHE—kidney cancer	2.21e-06	0.000573	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SLC5A5—kidney cancer	2.18e-06	0.000566	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.13e-06	0.000553	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPAT—kidney cancer	2.13e-06	0.000553	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CTNNA1—kidney cancer	2.11e-06	0.000548	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CTNNA1—kidney cancer	2.1e-06	0.000547	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SLC2A1—kidney cancer	2.1e-06	0.000546	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CA9—kidney cancer	2.1e-06	0.000545	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EIF4EBP1—kidney cancer	2.1e-06	0.000545	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HSPB1—kidney cancer	2.1e-06	0.000545	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EIF4EBP1—kidney cancer	2.09e-06	0.000543	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HSPB1—kidney cancer	2.09e-06	0.000543	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	2.08e-06	0.000541	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	2.07e-06	0.000538	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HSPB1—kidney cancer	2.07e-06	0.000538	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF2—kidney cancer	2.03e-06	0.000528	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CDKN2B—kidney cancer	2.03e-06	0.000526	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—FH—kidney cancer	1.98e-06	0.000514	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APRT—kidney cancer	1.98e-06	0.000514	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF1R—kidney cancer	1.97e-06	0.000511	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PSMD7—kidney cancer	1.95e-06	0.000507	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ANXA1—kidney cancer	1.95e-06	0.000507	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TSC1—kidney cancer	1.95e-06	0.000507	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TSC1—kidney cancer	1.95e-06	0.000505	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PSMD7—kidney cancer	1.95e-06	0.000505	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ANXA1—kidney cancer	1.95e-06	0.000505	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.93e-06	0.0005	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.93e-06	0.0005	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.93e-06	0.0005	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—RAF1—kidney cancer	1.9e-06	0.000492	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FLT1—kidney cancer	1.89e-06	0.000491	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FLT1—kidney cancer	1.88e-06	0.000489	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—IL2—kidney cancer	1.87e-06	0.000486	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.87e-06	0.000485	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPC3—kidney cancer	1.86e-06	0.000484	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CA2—kidney cancer	1.81e-06	0.00047	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CRABP1—kidney cancer	1.79e-06	0.000464	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—POMC—kidney cancer	1.78e-06	0.000463	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—POMC—kidney cancer	1.78e-06	0.000461	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALAD—kidney cancer	1.77e-06	0.000458	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—POMC—kidney cancer	1.76e-06	0.000457	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTP1—kidney cancer	1.75e-06	0.000456	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—JUNB—kidney cancer	1.75e-06	0.000455	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PAK1—kidney cancer	1.75e-06	0.000455	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—JUNB—kidney cancer	1.75e-06	0.000454	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PAK1—kidney cancer	1.75e-06	0.000454	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PAK1—kidney cancer	1.73e-06	0.000449	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—JUNB—kidney cancer	1.73e-06	0.000449	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.72e-06	0.000447	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL2—kidney cancer	1.7e-06	0.000441	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.68e-06	0.000437	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ABCB1—kidney cancer	1.66e-06	0.000431	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ITPR2—kidney cancer	1.66e-06	0.000431	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HIF1A—kidney cancer	1.62e-06	0.000421	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—POMC—kidney cancer	1.62e-06	0.00042	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TSC2—kidney cancer	1.62e-06	0.000419	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PGK1—kidney cancer	1.61e-06	0.000419	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.61e-06	0.000419	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—POMC—kidney cancer	1.61e-06	0.000419	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTM1—kidney cancer	1.61e-06	0.000419	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—POMC—kidney cancer	1.6e-06	0.000415	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LDHB—kidney cancer	1.58e-06	0.000411	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KDR—kidney cancer	1.55e-06	0.000402	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP1A1—kidney cancer	1.53e-06	0.000397	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTT1—kidney cancer	1.51e-06	0.000393	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ACHE—kidney cancer	1.51e-06	0.000393	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SCARB1—kidney cancer	1.43e-06	0.000372	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF2—kidney cancer	1.43e-06	0.000372	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF2—kidney cancer	1.43e-06	0.000371	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—APC—kidney cancer	1.43e-06	0.00037	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KIT—kidney cancer	1.43e-06	0.00037	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	1.43e-06	0.00037	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	1.42e-06	0.000369	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS1—kidney cancer	1.42e-06	0.000368	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF2—kidney cancer	1.41e-06	0.000367	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	1.41e-06	0.000366	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PSMD7—kidney cancer	1.39e-06	0.000361	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1R—kidney cancer	1.39e-06	0.00036	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1R—kidney cancer	1.38e-06	0.000359	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CA9—kidney cancer	1.37e-06	0.000357	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1R—kidney cancer	1.37e-06	0.000355	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—MAPK3—kidney cancer	1.37e-06	0.000355	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—POMC—kidney cancer	1.36e-06	0.000353	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—BRAF—kidney cancer	1.34e-06	0.000348	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—RAF1—kidney cancer	1.33e-06	0.000347	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—RAF1—kidney cancer	1.33e-06	0.000345	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—BCHE—kidney cancer	1.32e-06	0.000342	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—IL2—kidney cancer	1.32e-06	0.000342	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—RAF1—kidney cancer	1.32e-06	0.000342	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—IL2—kidney cancer	1.31e-06	0.000341	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.3e-06	0.000338	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—IL2—kidney cancer	1.3e-06	0.000338	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—MAPK1—kidney cancer	1.3e-06	0.000338	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.26e-06	0.000327	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—PIK3CA—kidney cancer	1.24e-06	0.000323	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—KRAS—kidney cancer	1.23e-06	0.000319	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL2—kidney cancer	1.2e-06	0.000311	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL2—kidney cancer	1.19e-06	0.00031	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL2—kidney cancer	1.18e-06	0.000307	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CRABP1—kidney cancer	1.17e-06	0.000303	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HIF1A—kidney cancer	1.14e-06	0.000296	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—POMC—kidney cancer	1.14e-06	0.000296	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TSC2—kidney cancer	1.14e-06	0.000295	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HIF1A—kidney cancer	1.14e-06	0.000295	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TSC2—kidney cancer	1.13e-06	0.000294	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—PIK3CA—kidney cancer	1.13e-06	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HIF1A—kidney cancer	1.13e-06	0.000292	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TSC2—kidney cancer	1.12e-06	0.000292	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RAF1—kidney cancer	1.12e-06	0.000291	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RELA—kidney cancer	1.11e-06	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ERBB2—kidney cancer	1.11e-06	0.000288	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MTOR—kidney cancer	1.09e-06	0.000284	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KDR—kidney cancer	1.09e-06	0.000283	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KDR—kidney cancer	1.09e-06	0.000282	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ITPR2—kidney cancer	1.09e-06	0.000282	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KDR—kidney cancer	1.08e-06	0.00028	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTP1—kidney cancer	1.05e-06	0.000272	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CDKN1B—kidney cancer	1.03e-06	0.000266	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KIT—kidney cancer	1e-06	0.000261	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APC—kidney cancer	1e-06	0.000261	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL2—kidney cancer	1e-06	0.000261	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APC—kidney cancer	1e-06	0.00026	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KIT—kidney cancer	1e-06	0.00026	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ABCB1—kidney cancer	9.93e-07	0.000258	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KIT—kidney cancer	9.92e-07	0.000257	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APC—kidney cancer	9.92e-07	0.000257	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTT1—kidney cancer	9.9e-07	0.000257	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ACHE—kidney cancer	9.9e-07	0.000257	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCND1—kidney cancer	9.79e-07	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—JUN—kidney cancer	9.77e-07	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CTNNB1—kidney cancer	9.69e-07	0.000252	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTM1—kidney cancer	9.64e-07	0.00025	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	9.62e-07	0.00025	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	9.59e-07	0.000249	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—POMC—kidney cancer	9.56e-07	0.000248	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—POMC—kidney cancer	9.53e-07	0.000248	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	9.5e-07	0.000247	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PTEN—kidney cancer	9.45e-07	0.000245	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—BRAF—kidney cancer	9.44e-07	0.000245	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—POMC—kidney cancer	9.44e-07	0.000245	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—BRAF—kidney cancer	9.41e-07	0.000244	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SCARB1—kidney cancer	9.37e-07	0.000243	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—BRAF—kidney cancer	9.32e-07	0.000242	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS1—kidney cancer	9.27e-07	0.000241	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	9.15e-07	0.000238	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP1A1—kidney cancer	9.14e-07	0.000237	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	9.12e-07	0.000237	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSMD7—kidney cancer	9.1e-07	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—kidney cancer	9.09e-07	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	9.04e-07	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	8.75e-07	0.000227	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	8.72e-07	0.000226	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—KRAS—kidney cancer	8.65e-07	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	8.63e-07	0.000224	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—BCHE—kidney cancer	8.62e-07	0.000224	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—KRAS—kidney cancer	8.62e-07	0.000224	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—KRAS—kidney cancer	8.53e-07	0.000222	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—kidney cancer	8.53e-07	0.000222	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.52e-07	0.000221	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.23e-07	0.000214	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK3—kidney cancer	8.07e-07	0.00021	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	7.94e-07	0.000206	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTEN—kidney cancer	7.93e-07	0.000206	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	7.92e-07	0.000206	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RAF1—kidney cancer	7.88e-07	0.000205	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RAF1—kidney cancer	7.86e-07	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MYC—kidney cancer	7.85e-07	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RELA—kidney cancer	7.85e-07	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	7.84e-07	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RELA—kidney cancer	7.82e-07	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ERBB2—kidney cancer	7.8e-07	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RAF1—kidney cancer	7.78e-07	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ERBB2—kidney cancer	7.77e-07	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RELA—kidney cancer	7.75e-07	0.000201	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ERBB2—kidney cancer	7.7e-07	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MTOR—kidney cancer	7.7e-07	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK1—kidney cancer	7.68e-07	0.000199	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MTOR—kidney cancer	7.67e-07	0.000199	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MTOR—kidney cancer	7.6e-07	0.000197	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KRAS—kidney cancer	7.25e-07	0.000188	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	7.22e-07	0.000188	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	7.2e-07	0.000187	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	7.13e-07	0.000185	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL2—kidney cancer	7.07e-07	0.000184	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL2—kidney cancer	7.05e-07	0.000183	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL2—kidney cancer	6.98e-07	0.000181	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCND1—kidney cancer	6.89e-07	0.000179	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—JUN—kidney cancer	6.88e-07	0.000179	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCND1—kidney cancer	6.87e-07	0.000178	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTP1—kidney cancer	6.86e-07	0.000178	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—JUN—kidney cancer	6.85e-07	0.000178	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	6.82e-07	0.000177	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—POMC—kidney cancer	6.82e-07	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCND1—kidney cancer	6.8e-07	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	6.8e-07	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—JUN—kidney cancer	6.79e-07	0.000176	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	6.74e-07	0.000175	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	6.66e-07	0.000173	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PTEN—kidney cancer	6.65e-07	0.000173	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTEN—kidney cancer	6.63e-07	0.000172	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTEN—kidney cancer	6.57e-07	0.00017	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCB1—kidney cancer	6.49e-07	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TP53—kidney cancer	6.45e-07	0.000167	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTM1—kidney cancer	6.3e-07	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—kidney cancer	6.01e-07	0.000156	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—kidney cancer	5.99e-07	0.000156	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.98e-07	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—kidney cancer	5.93e-07	0.000154	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK3—kidney cancer	5.68e-07	0.000148	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK3—kidney cancer	5.66e-07	0.000147	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK3—kidney cancer	5.61e-07	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CA—kidney cancer	5.59e-07	0.000145	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MYC—kidney cancer	5.53e-07	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MYC—kidney cancer	5.51e-07	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MYC—kidney cancer	5.46e-07	0.000142	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—kidney cancer	5.44e-07	0.000141	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK1—kidney cancer	5.41e-07	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK1—kidney cancer	5.39e-07	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK1—kidney cancer	5.34e-07	0.000139	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KRAS—kidney cancer	5.11e-07	0.000133	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KRAS—kidney cancer	5.09e-07	0.000132	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KRAS—kidney cancer	5.04e-07	0.000131	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTEN—kidney cancer	4.74e-07	0.000123	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	4.69e-07	0.000122	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	4.68e-07	0.000121	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	4.63e-07	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TP53—kidney cancer	4.54e-07	0.000118	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TP53—kidney cancer	4.52e-07	0.000117	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TP53—kidney cancer	4.48e-07	0.000116	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—POMC—kidney cancer	4.46e-07	0.000116	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—kidney cancer	3.55e-07	9.23e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.34e-07	8.68e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTEN—kidney cancer	3.1e-07	8.05e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.19e-07	5.68e-05	CbGpPWpGaD
